1-3 of 3
Julie D. Asch, MD
Close
Sort by
Journal Articles

A Multicenter Phase II Study Using a Dose Intensified Pegylated-Asparaginase Pediatric Regimen in Adults with Untreated Acute Lymphoblastic Leukemia: A DFCI ALL Consortium Trial

Daniel J. DeAngelo, MD PhD, Kristen Stevenson, MS, Donna S Neuberg, ScD, Lewis B. Silverman, MD, Karen K. Ballen, MD, Julie D. Asch, MD, Yasser Abou Mourad, MD, Kristjan Paulson, MD FRCPC, Matthew D. Seftel, MBChB, FRCP(C), MRCP, David Avigan, MD, Julie Bergeron, MD, Stephen Couban, MD, William Blum, MD, John Storring, MD, Martha Wadleigh, MD, David P. Steensma, MD, Jeffrey Supko, PhD, Stephen E. Sallan, MD, Richard M. Stone, MD
Journal: Blood
Blood (2015) 126 (23): 80.
https://doi.org/10.1182/blood.V126.23.80.80
Published: 2015
Journal Articles

Genomic Analysis of Adult B-ALL Identifies Changes in Copy Number Profile at Relapse and IKZF1/CDKN2A Co-Deletion at Diagnosis As a Marker of Shorter Survival

Shiven B. Patel, MD, Clinton C. Mason, PhD, Martha Glenn, MD, Christian N. Paxton, PhD, Sarah T. South, PhD, Melissa H. Cessna, MD, Julie D. Asch, MD, Erin F. Cobain, MD, Dale Bixby, MD PhD, Lauren B. Smith, MD, Shalini C. Reshmi, PhD, Julie M. Gastier-Foster, PhD, Joshua D. Schiffman, MD, Rodney R. Miles, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1427.
https://doi.org/10.1182/blood.V126.23.1427.1427
Published: 2015
Journal Articles

Intensified Chemotherapy for Older Patients with Acute Lymphoblastic Leukemia (ALL): A Phase II Study from the Dana Farber Cancer Institute (DFCI) ALL Consortium

Amir T. Fathi, MD, Daniel J DeAngelo, Kristen E. Stevenson, MS, Jonathan E. Kolitz, MD, Julie D. Asch, MD, Philip C. Amrein, MD, Eyal C. Attar, MD, David P. Steensma, MD, Martha Wadleigh, MD, Christine Connolly, Ilene Galinsky, ANP, Richard M. Stone, MD, Donna S. Neuberg, ScD, Karen K. Ballen, MD
Journal: Blood
Blood (2014) 124 (21): 3714.
https://doi.org/10.1182/blood.V124.21.3714.3714
Published: 2014